Rossby Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,380
Closed -$72.9K 2315
2026
Q1
$72.9K Sell
1,380
-3,100
-69% -$158K 0.01% 630
2025
Q4
$229K Sell
4,480
-200
-4% -$9.25K 0.07% 259
2025
Q3
$182K Hold
4,680
0.06% 303
2025
Q2
$141K Sell
4,680
-500
-10% -$14.3K 0.05% 316
2025
Q1
$147K Buy
+5,180
New +$164K 0.06% 286

Other funds holding SBIO

Rossby Financial's SBIO Position: Q2 2026 in Review

Rossby Financial sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 1,380 shares — an estimated $72.9K sold.

Rossby Financial first reported a position in SBIO in Q1 2025 and held it in 5 quarters. The position peaked at $229K in Q4 2025. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Rossby Financial reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Rossby Financial sold 1,380 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $72.9K.
  • Rossby Financial first reported a position in ALPS Medical Breakthroughs ETF in Q1 2025 and held it in 5 quarters.
  • Rossby Financial's ALPS Medical Breakthroughs ETF position peaked at $229K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.